The economic burden of asthma: direct and indirect costs in Switzerland

Asthma mortality increased in Switzerland between 1980 and 1994. This study aimed to assess the economic burden of asthma in this country. Chart reviews were conducted for the last five patients seen for asthma in physician practices in 1996 and 1997. Direct expenditures and indirect costs for asthma-related morbidity were determined. A total of 589 patient charts were completely analysed, including 117 children's charts, obtained from 120 office-based physicians. The annual direct medical costs were CHF 1,778 and the mean annual indirect costs were CHF 1,019 per patient for all patients. The total estimated cost of asthma in Switzerland in 1997 was nearly CHF 1,252 million. Direct medical expenditures approached CHF 762 million, or 61% of the total. In 1997, the indirect costs for asthma were estimated to have exceeded CHF 490 million. Of these costs CHF 123 million (25%) was associated with morbidity and nearly CHF 368 million (75%) was associated with looking after asthmatic patients who had to be cared for at home. This study provides evidence that asthma is a major healthcare cost factor in Switzerland, amounting to approximately CHF 1,200 million per year. The data suggest that cost savings can be achieved by improving primary care for asthma in an ambulatory setting.

This article has been cited by other articles:

				C. K. W. Lai, Y-Y. Kim, S-H. Kuo, M. Spencer, A. E. Williams, and on behalf of the Asthma Insights and Reality in As Cost of asthma in the Asia-Pacific region Eur. Respir. Rev., June 1, 2006; 15(98): 10 - 16. [Abstract] [Full Text] [PDF]

				L. Nathell Effects on sick leave of an inpatient rehabilitation programme for asthmatics in a randomized trial Scand J Public Health, January 1, 2005; 33(1): 57 - 64. [Abstract] [PDF]

				L. Antonicelli, C. Bucca, M. Neri, F. De Benedetto, P. Sabbatani, F. Bonifazi, H-G. Eichler, Q. Zhang, and D.D. Yin Asthma severity and medical resource utilisation Eur. Respir. J., May 1, 2004; 23(5): 723 - 729. [Abstract] [Full Text] [PDF]

				V. S. Kocevar, H. Bisgaard, L. Jonsson, E. Valovirta, F. Kristensen, D. D. Yin, and J. Thomas III Variations in Pediatric Asthma Hospitalization Rates and Costs Between and Within Nordic Countries Chest, May 1, 2004; 125(5): 1680 - 1684. [Abstract] [Full Text] [PDF]

				C.A. Stevens, D. Turner, C.E. Kuehni, J.M. Couriel, and M. Silverman The economic impact of preschool asthma and wheeze Eur. Respir. J., June 1, 2003; 21(6): 1000 - 1006. [Abstract] [Full Text] [PDF]

				B. Schramm, B. Ehlken, A. Smala, K. Quednau, K. Berger, and D. Nowak Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study Eur. Respir. J., January 1, 2003; 21(1): 116 - 122. [Abstract] [Full Text] [PDF]

				C.E. Kuehni and U. Frey Age-related differences in perceived asthma control in childhood: guidelines and reality Eur. Respir. J., October 1, 2002; 20(4): 880 - 889. [Abstract] [Full Text] [PDF]

				E. Valovirta, V. Sazonov Kocevar, M. Kaila, M. Kajosaari, A. Koivikko, K. Korhonen, O. Linna, M. Makela, K. Remes, and R.H. Ben-Joseph Inpatient resource utilisation in younger (2-5 yrs) and older (6-14 yrs) asthmatic children in Finland Eur. Respir. J., August 1, 2002; 20(2): 397 - 402. [Abstract] [Full Text] [PDF]

				P. Godard, P. Chanez, L. Siraudin, N. Nicoloyannis, and G. Duru Costs of asthma are correlated with severity: a 1-yr prospective study Eur. Respir. J., January 1, 2001; 19(1): 61 - 67. [Abstract] [Full Text] [PDF]